Glen Eagle Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-110
| Closed | -$1.33K | – | 984 |
|
|
2021
Q3 | $1.33K | Hold |
110
| – | – | ﹤0.01% | 971 |
|
|
2021
Q2 | $2.33K | Hold |
110
| – | – | ﹤0.01% | 903 |
|
|
2021
Q1 | $3.09K | Sell |
110
-155
| -58% | -$4.35K | ﹤0.01% | 829 |
|
|
2020
Q4 | $6.89K | Buy |
265
+85
| +47% | +$2.21K | ﹤0.01% | 689 |
|
|
2020
Q3 | $6.69K | Buy |
180
+20
| +13% | +$743 | ﹤0.01% | 659 |
|
|
2020
Q2 | $8.21K | Hold |
160
| – | – | ﹤0.01% | 595 |
|
|
2020
Q1 | $5.05K | Buy |
160
+30
| +23% | +$946 | ﹤0.01% | 615 |
|
|
2019
Q4 | $7.75K | Hold |
130
| – | – | ﹤0.01% | 641 |
|
|
2019
Q3 | $4.77K | Hold |
130
| – | – | ﹤0.01% | 642 |
|
|
2019
Q2 | $6.05K | Buy |
130
+50
| +63% | +$2.33K | ﹤0.01% | 596 |
|
|
2019
Q1 | $3.21K | Buy |
+80
| New | +$3.21K | ﹤0.01% | 620 |
|